top of page

Tiffany Varughese, PharmD: SCLC Current Standard of Care and Emerging Therapies

Tiffany Varughese, PharmD

Medical Director- Thoracic Oncology, AstraZeneca


This video was recorded April 16, 2024 at the 2nd Annual LiveLung Small Cell Summit The 2nd Annual LiveLung Small Cell Summit was held April 16-17, 2024 in Raleigh, NC. We were honored to bring together Small Cell Lung Cancer Patients and their caregivers with ten renowned experts in the field of SCLC, including Tiffany Varughese, PharmD.





About the Speaker

Tiffany Varughese, PharmD is a medical director at AstraZeneca specializing in lung cancer. She is passionate about advancing patient care and improving patient outcomes for those affected by this challenging disease. Her expertise, combined with a compassionate approach, drives her commitment to making a meaningful difference in the lives of patients.


The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical. The 2nd Annual LiveLung Small Cell Lung Cancer Summit was made possible in-part by grants from AstraZeneca, Amgen, Henlius, Jazz Pharmaceutical, Catalyst, and Gilead.


This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.


LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.

Comentarios


bottom of page